IMR Press / EJGO / Volume 7 / Issue 1 / pii/1986010

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology

Show Less
1 Gynaecologische Gezwelziekten, Universitair Ziekenhuis Saint Rafael, Katholieke Universiteit Leuven, Belgium
Eur. J. Gynaecol. Oncol. 1986, 7(1), 45–50;
Published: 10 February 1986

In the therapeutic schemes of the hormone-dependent gynecologic cancers, the combined administration of tamoxifen and medroxyprogesterone, generally, scores better results. The highly hormone-dependent tumors (ER+, PgR +) respond very well to a combined, simul­taneous treatment. The strictly hormone-dependent (ER+, PgR -) and the potentially hormone-dependent (ER-, PgR-) tumors seem to be most efficiently treated by means of a combined, successive scheme.

Back to top